Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat

F Javoy et al. Naunyn Schmiedebergs Arch Pharmacol. 1977 Apr.

. 1977 Apr;297(3):233-9.

doi: 10.1007/BF00509266.

No abstract available

Similar articles

Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
Racagni G, Bruno F, Cattabeni F, Maggi A, Di Giulio AM, Parenti M, Groppetti A. Racagni G, et al. Brain Res. 1977 Oct 7;134(2):353-8. doi: 10.1016/0006-8993(77)91079-4. Brain Res. 1977. PMID: 890495 No abstract available.
Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones.
Euvrard C, Javoy F, Herbet A, Glowinski J. Euvrard C, et al. Eur J Pharmacol. 1977 Feb 7;41(3):281-9. doi: 10.1016/0014-2999(77)90321-1. Eur J Pharmacol. 1977. PMID: 138594
The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
Olianas MC, De Montis GM, Mulas G, Tagliamonte A. Olianas MC, et al. Eur J Pharmacol. 1978 Jun 1;49(3):233-41. doi: 10.1016/0014-2999(78)90098-5. Eur J Pharmacol. 1978. PMID: 566207 No abstract available.
Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
Fuxe K, Goldstein M, Hökfelt T, Jonsson G, Lidbrink P. Fuxe K, et al. Adv Neurol. 1974;5:405-19. Adv Neurol. 1974. PMID: 4374065 Review. No abstract available.
Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
Kim JS. Kim JS. Adv Biochem Psychopharmacol. 1978;19:217-33. Adv Biochem Psychopharmacol. 1978. PMID: 29447 Review.